Research > Chronic diseases, Surgery and Health Care

Vascular and renal translational research group

Number of publications
337
Publications search
  • Bermúdez-López M; Martínez-Alonso M; Castro-Boqué E; Betriu À; Cambray S; Farràs C; Barbé F; Pamplona R; Lecube A; Mauricio D; Purroy F; Valdivielso JM; Fernández E; ILERVAS project collaborators

    Subclinical atheromatosis localization and burden in a low-to-moderate cardiovascular risk population: the ILERVAS study.

    Revista Española De Cardiología (english Ed.) 74 1042-1053. .

    [doi:10.1016/j.rec.2020.09.015]

  • Solache-Berrocal G; Rolle-Sóñora V; Martín-Fernández N; Cambray S; Valdivielso JM; Rodríguez I

    CYP24A1 and KL polymorphisms are associated with the extent of vascular calcification but do not improve prediction of cardiovascular events.

    NEPHROLOGY DIALYSIS TRANSPLANTATION 36 2076-2083. .

    [doi:10.1093/ndt/gfaa240]

  • Caus M; Eritja À; Bozic M

    Role of microRNAs in Obesity-Related Kidney Disease.

    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 22 -. .

    [doi:10.3390/ijms222111416]

  • Valdivielso JM; Balafa O; Ekart R; Ferro CJ; Mallamaci F; Mark PB; Rossignol P; Sarafidis P; Del Vecchio L; Ortiz A

    Correction to: Hyperkalemia in Chronic Kidney Disease in the New Era of Kidney Protection Therapies.

    DRUGS 81 1819-1819. .

    [doi:10.1007/s40265-021-01617-8]

  • Castelblanco E; Sarrias MR; Betriu À; Soldevila B; Barranco-Altirriba M; Franch-Nadal J; Valdivielso JM; Bermudez-Lopez M; Groop PH; Fernández E; Alonso N; Mauricio D

    Circulating CD5L is associated with cardiovascular events and all-cause mortality in individuals with chronic kidney disease.

    Aging-US 13 22690-22709. .

    [doi:10.18632/aging.203615]

  • Alonso-Perez E; Forné C; Soro M; Valls M; Manganelli AG; Valdivielso JM

    Health Care Costs in Patients with and without Secondary Hyperparathyroidism in Spain.

    Advances in Therapy 38 5333-5344. .

    [doi:10.1007/s12325-021-01895-4]

  • Granado-Casas M; Martinez-Gonzalez D; Martínez-Alonso M; Dòria M; Alcubierre N; Valls J; Julve J; Verdú-Soriano J; Mauricio D

    Psychometric Validation of the Cardiff Wound Impact Schedule Questionnaire in a Spanish Population with Diabetic Foot Ulcer.

    Journal of Clinical Medicine 10 4023-. .

    [doi:10.3390/jcm10174023]

  • Mota-Zamorano S; Robles NR; González LM; Valdivielso JM; Lopez-Gomez J; Cancho B; García-Pino G; Gervasini G

    Genetics Variants in the Epoxygenase Pathway of Arachidonic Metabolism Are Associated with Eicosanoids Levels and the Risk of Diabetic Nephropathy.

    Journal of Clinical Medicine 10 3980-. .

    [doi:10.3390/jcm10173980]

  • Valdivielso, JM; Balafa, O; Ekart, R; Ferro, CJ; Mallamaci, F; Mark, PB; Rossignol, P; Sarafidis, P; del Vecchio, L; Ortiz, A

    Hyperkalemia in Chronic Kidney Disease in the New Era of Kidney Protection Therapies

    DRUGS 81 1467-1489. .

    [doi:10.1007/s40265-021-01555-5]

  • Buxeda, A; Arias-Cabrales, C; Perez-Saez, MJ; Cacho, J; Pelegrin, SC; Melilli, E; Aladren, MJ; Galeano, C; Lorenzo, I; Mazuecos, A; Saura, IM; Franco, A; Ruiz-Fuentes, MD; Sanchez-Camara, LA; Siverio, O; Martin, ML; Gonzalez-Garcia, E; Lopez, V; Martin-Moreno, PL; Moina, I; Berrio, EM; Moreso, F; Portoles, JM; Santana-Estupinan, R; Zarraga, S; Canal, C; Sanchez-Alvarez, E; Pascual, J; Crespo, M; Spanish Soc Nephrology COVID-19 Gr

    Use and Safety of Remdesivir in Kidney Transplant Recipients With COVID-19

    Kidney International Reports 6 2305-2315. .

    [doi:10.1016/j.ekir.2021.06.023]

  • Carpio JD; Marco MP; Martin ML; Ramos N; de la Torre J; Prat J; Torres MJ; Montoro B; Ibarz M; Pico S; Falcon G; Canales M; Huertas E; Romero I; Nieto N; Gavaldà R; Segarra A

    Development and Validation of a Model to Predict Severe Hospital-Acquired Acute Kidney Injury in Non-Critically Ill Patients.

    Journal of Clinical Medicine 10 3959-. .

    [doi:10.3390/jcm10173959]

  • González LM; Robles NR; Mota-Zamorano S; Valdivielso JM; López-Gómez J; Gervasini G

    Genetic Variants in PGE2 Receptors Modulate the Risk of Nephrosclerosis and Clinical Outcomes in These Patients.

    Journal of Personalized Medicine 11 772-. .

    [doi:10.3390/jpm11080772]